Johnson & Johnson's COVID-19 Vaccine Is Linked To A Rare Neurological Disorder

The Johnson & Johnson coronavirus vaccine has been linked to an extremely rare neurological disorder, Guillain-Barré syndrome (GBS), according to the Centers for Disease Control and Prevention. In a letter to the company, the FDA classified the chances of getting GBS after vaccination as being "very low." Still, it said J&J vaccine recipients should seek medical attention if they have symptoms including tingling sensations, difficulty walking or difficulty with facial movements.